We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: The treatment approach combines taxane chemotherapy with trastuzumab and pertuzumab for 12 weeks before surgery. Patients achieving pCR receive no further chemotherapy and continue dual HER2 blockade for one year (Image Credit: Shutterstock)

Tumor Markers Help Predict Response to Less Intensive HER2+ Chemotherapy

Tumor markers and molecular testing predict complete response to shorter therapy in HER2-positive breast cancer. More...
07 Oct 2026
Image Credit: Shutterstock

Expanded Sequencing Panel Supports Myeloid Malignancy Variant Profiling

Pillar Biosciences has launched the RUO oncoReveal Myeloid v2 NGS Panel, expanding coverage for myeloid malignancies from 58 to 80 gene targets. More...
07 Oct 2026
.Image: Paradigm for the diagnosis of Primary mitochondrial disorders (Johan L K Van Hove et al. EMBO Molecular Medicine, 2026. https://doi.org/10.1038/s44321-026-00497-3)

Functional Testing From Skin Biopsy Improves Detection of Mitochondrial Disease

Functional testing of skin-derived fibroblasts improves primary mitochondrial disease diagnosis and reduces invasive biopsies. More...
07 Oct 2026
Image: As the Bundibugyo Ebola outbreak continues in the DRC, testing demand is exceeding laboratory capacity, underscoring the need for public-private partnerships to strengthen the response (Image Credit: 123RF)

New Molecular Testing Support to Strengthen Ebola Surveillance in DRC

New lab instruments support local validation of Ebola PCR, boosting case detection and surveillance capacity. More...
07 Oct 2026
Image: Dr. Gavin Arno (left) and Dr. Richard Steet in the research laboratory at the Greenwood Genetic Center (Photo courtesy of Greenwood Genetic Center)

Genetic Study Links Inherited Blindness to Gene Tied to Rare Metabolic Disorder

New findings link genetic variants to retinitis pigmentosa without broader metabolic disease signs. More...
07 Oct 2026
Image: A new Manchester study is investigating whether breast milk could help detect breast cancer earlier than blood tests or scans, particularly in women who develop the disease during or shortly after pregnancy. (Photo courtesy of The University of Manchester)

Breast Milk DNA Test Investigated for Early Breast Cancer Detection

Breast milk could signal breast cancer during or shortly after pregnancy earlier than blood tests or imaging. More...
07 Oct 2026
Image: Guardant Reveal is a tissue-free liquid biopsy test that detects MRD and monitors recurrence in early-stage colorectal, breast, and lung cancers to help guide treatment decisions (Photo courtesy of Guardant Health)

Blood-Based MRD Test Predicts Recurrence Risk After Melanoma Surgery

A tissue-free liquid biopsy detects ctDNA MRD to predict melanoma recurrence earlier, with 81% sensitivity and 100% specificity. More...
07 Oct 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Copyright © 2000-2026 Globetech Media. All rights reserved.